vs
Side-by-side financial comparison of Arbutus Biopharma Corp (ABUS) and CHICAGO RIVET & MACHINE CO (CVR). Click either name above to swap in a different company.
Arbutus Biopharma Corp is the larger business by last-quarter revenue ($10.7M vs $6.0M, roughly 1.8× CHICAGO RIVET & MACHINE CO). Arbutus Biopharma Corp runs the higher net margin — 23.5% vs -19.3%, a 42.8% gap on every dollar of revenue. On growth, Arbutus Biopharma Corp posted the faster year-over-year revenue change (522.2% vs 45.9%). Over the past eight quarters, CHICAGO RIVET & MACHINE CO's revenue compounded faster (-12.7% CAGR vs -13.2%).
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
Chicago Pneumatic, also known as "CP", is an industrial manufacturer providing power tools, air compressors, generators, light towers and hydraulic equipment. Products are sold in more than 150 countries through a worldwide distribution network. CP is active on markets such as tools for industrial production, vehicle service, maintenance repair operation for mining, construction, infrastructure equipment.
ABUS vs CVR — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $10.7M | $6.0M |
| Net Profit | $2.5M | $-1.2M |
| Gross Margin | — | 2.7% |
| Operating Margin | 13.9% | -15.3% |
| Net Margin | 23.5% | -19.3% |
| Revenue YoY | 522.2% | 45.9% |
| Net Profit YoY | 112.7% | 68.0% |
| EPS (diluted) | $0.01 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $6.0M | ||
| Q3 25 | — | $7.4M | ||
| Q2 25 | $10.7M | $7.3M | ||
| Q1 25 | — | $7.2M | ||
| Q4 24 | — | $4.1M | ||
| Q3 24 | — | $7.0M | ||
| Q2 24 | — | $8.1M | ||
| Q1 24 | — | $7.9M |
| Q4 25 | — | $-1.2M | ||
| Q3 25 | — | $67.6K | ||
| Q2 25 | $2.5M | $-395.0K | ||
| Q1 25 | — | $401.0K | ||
| Q4 24 | — | $-3.6M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $142.1K | ||
| Q1 24 | — | $-698.0K |
| Q4 25 | — | 2.7% | ||
| Q3 25 | — | 18.1% | ||
| Q2 25 | — | 13.4% | ||
| Q1 25 | — | 22.9% | ||
| Q4 24 | — | -43.7% | ||
| Q3 24 | — | 10.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 9.5% |
| Q4 25 | — | -15.3% | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | 13.9% | -5.7% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | -86.4% | ||
| Q3 24 | — | -11.8% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | -11.5% |
| Q4 25 | — | -19.3% | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | 23.5% | -5.4% | ||
| Q1 25 | — | 5.5% | ||
| Q4 24 | — | -88.0% | ||
| Q3 24 | — | -20.8% | ||
| Q2 24 | — | 1.8% | ||
| Q1 24 | — | -8.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $0.01 | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.4M | $1.7M |
| Total DebtLower is stronger | $0 | — |
| Stockholders' EquityBook value | $83.0M | $18.8M |
| Total Assets | $103.3M | $23.3M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.7M | ||
| Q3 25 | — | $1.7M | ||
| Q2 25 | $37.4M | $1.2M | ||
| Q1 25 | — | $765.6K | ||
| Q4 24 | — | $2.2M | ||
| Q3 24 | — | $2.2M | ||
| Q2 24 | — | $2.6M | ||
| Q1 24 | — | $2.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $18.8M | ||
| Q3 25 | — | $20.0M | ||
| Q2 25 | $83.0M | $20.0M | ||
| Q1 25 | — | $20.4M | ||
| Q4 24 | — | $20.0M | ||
| Q3 24 | — | $23.7M | ||
| Q2 24 | — | $25.2M | ||
| Q1 24 | — | $25.2M |
| Q4 25 | — | $23.3M | ||
| Q3 25 | — | $24.0M | ||
| Q2 25 | $103.3M | $23.6M | ||
| Q1 25 | — | $24.1M | ||
| Q4 24 | — | $23.4M | ||
| Q3 24 | — | $26.4M | ||
| Q2 24 | — | $27.3M | ||
| Q1 24 | — | $27.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.7M | $116.4K |
| Free Cash FlowOCF − Capex | — | $24.3K |
| FCF MarginFCF / Revenue | — | 0.4% |
| Capex IntensityCapex / Revenue | 0.0% | 1.5% |
| Cash ConversionOCF / Net Profit | -6.24× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $116.4K | ||
| Q3 25 | — | $638.0K | ||
| Q2 25 | $-15.7M | $28.2K | ||
| Q1 25 | — | $-2.0M | ||
| Q4 24 | — | $-60.1K | ||
| Q3 24 | — | $-58.2K | ||
| Q2 24 | — | $363.5K | ||
| Q1 24 | — | $-398.8K |
| Q4 25 | — | $24.3K | ||
| Q3 25 | — | $492.1K | ||
| Q2 25 | — | $-22.8K | ||
| Q1 25 | — | $-2.1M | ||
| Q4 24 | — | $-118.1K | ||
| Q3 24 | — | $-368.9K | ||
| Q2 24 | — | $58.0K | ||
| Q1 24 | — | $-491.8K |
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 6.7% | ||
| Q2 25 | — | -0.3% | ||
| Q1 25 | — | -28.3% | ||
| Q4 24 | — | -2.9% | ||
| Q3 24 | — | -5.3% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | -6.3% |
| Q4 25 | — | 1.5% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.8% | ||
| Q1 24 | — | 1.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | 9.44× | ||
| Q2 25 | -6.24× | — | ||
| Q1 25 | — | -5.01× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 2.56× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABUS
Segment breakdown not available.
CVR
| Fastener | $5.1M | 85% |
| Other | $890.7K | 15% |
